Does 6% hydroxyethyl starch 130/0.4 impact differently on blood glucose than 4% gelatin in patients receiving open heart surgery?

Perfusion

Volumn 27, Issue 2, 2012, Pages 113-118

  Lou, S ^a   Bian, L ^a   Long, C ^a   Wang, Z ^a   Ma, J ^a   Zhou, B ^a  

^a FUWAI HOSPITAL   (China)

Author keywords

adult; artificial colloid; cardiac surgery; cardiopulmonary bypass; glucose

Indexed keywords

GELATIN; GLUCOSE; HETASTARCH; INSULIN; ST THOMAS HOSPITAL SOLUTION;

ADULT; ARTICLE; CONTROLLED STUDY; DEEP HYPOTHERMIC CIRCULATORY ARREST; ELECTIVE SURGERY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; MAJOR CLINICAL STUDY; MALE; OPEN HEART SURGERY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ADULT; ANALYSIS OF VARIANCE; BLOOD GLUCOSE; CARDIOPULMONARY BYPASS; FEMALE; GELATIN; HETASTARCH; HUMANS; MALE; MIDDLE AGED; PLASMA SUBSTITUTES; THORACIC SURGERY;

EID: 84863377389     PISSN: 02676591     EISSN: 1477111X     Source Type: Journal    
DOI: 10.1177/0267659111426920     Document Type: Article

References (17)

1. Egi M, Bellomo R, Stachowski E, et al. Blood glucose concentration and outcome of critical illness: the impact of diabetes. Crit Care Med. 2008 ; 36: 2249-2255
2. van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in critically ill patients. N Engl J Med. 2001: 345 1359-1367
3. Kavanagh BP, McCowen KC. Clinical practice. Glycemic control in the ICU. N Engl J Med. 2010 ; 363: 2540-2546
4. Lazar HL, McDonnell M, Chipkin SR, et al. The Society of Thoracic Surgeons practice guideline series: blood glucose management during adult cardiac surgery. Ann Thorac Surg. 2009 ; 87: 663-669
5. Hiltebrand LB, Kimberger O, Arnberger M, Brandt S, Kurz A, Sigurdsson GH. Crystalloids versus colloids for goal-directed fluid therapy in major surgery. Crit Care. 2009 ; 13: R40
6. Choi YS, Shim JK, Hong SW, Kim JC, Kwak YL. Comparing the effects of 5% albumin and 6% hydroxyethyl starch 130/0.4 on coagulation and inflammatory response when used as priming solutions for cardiopulmonary bypass. Minerva Anestesiol. 2010 ; 76: 584-591
7. Boussekey N, Darmon R, Langlois J, et al. Resuscitation with low volume hydroxyethylstarch 130 kDa/0.4 is not associated with acute kidney injury. Crit Care. 2010 ; 14: R40
8. Russ M, Koch V, Keckel T, Boemke W, Hiebl B, Unger JK. Six percent hydroxyethyl starch 130/0.4 impacts differently on blood glucose than 4% gelatin in a swine model of mixed acidaemia. Eur J Anaesthesioy. 2009 ; 26: 1026-1031
9. Unger JK, Haltern C, Kobela JB, et al. Hydroxyethyl starch 130 kd/0.4 and albumin improve CVVH biocompatibility whereas gelatin and hydroxyethyl starch 200 kd/0.5 lead to adverse side effects of CVVH in anesthetized pigs. Shock. 2006 ; 25: 533-545
10. Doig GS, Simpson F. Randomization and allocation concealment: a practical guide for researchers. J Crit Care. 2005 ; 20: 187-191 (Pubitemid 41219643)
11. Finfer S, Chittock DR, et al. Intensive versus conventional glucose control in critically ill patients. N Engl J Med. 2009 ; 360: 1283-1297
12. Al-Dorzi HM, Tamim HM, Arabi YM. Glycaemic fluctuation predicts mortality in critically ill patients. Anaesth Intensive Care. 2010 ; 38: 695-702
13. Donatelli F, Cavagna P, Di Dedda G, et al. Correlation between pre-operative metabolic syndrome and persistent blood glucose elevation during cardiac surgery in non-diabetic patients. Acta Anaesthesiol Scand. 2008 ; 52: 1103-1110
14. Prasad AA, Kline SM, Schuler HG, Sukernik MR. Clinical and laboratory correlates of excessive and persistent blood glucose elevation during cardiac surgery in nondiabetic patients: a retrospective study. J Cardiothorac Vasc Anesth. 2007 ; 21: 843-846 (Pubitemid 350192273)
15. Zhou Y, Liu BL, Liu K, et al. Establishment of the insulin resistance induced by inflammatory response in 3T3-L1 preadipocytes cell line. Inflammation. 2008 ; 31: 355-364
16. Feng X, Yan W, Wang Z, et al. Hydroxyethyl starch, but not modified fluid gelatin, affects inflammatory response in a rat model of polymicrobial sepsis with capillary leakage. Anesth Analg. 2007 ; 104: 624-630
17. Boldt J. Modern rapidly degradable hydroxyethyl starches: current concepts. Anesth Analg. 2009 ; 108: 1574-1582